Table 1 Experimental design of vaccination-challenge experiments
Group | Vaccination | Age in weeks | Challenge strain (13 weeks) |
|---|---|---|---|
Experiment 1 (n) | Â | Â | Â |
CON (6) | Mock | 5 and 9 | 07 V063 |
07 V063i (6) | BEI-inactivated 07 V063 | 5 and 9 | 07 V063 |
LVi (6) | BEI-inactivated LV | 5 and 9 | 07 V063 |
PROi (6) | Progressis® | 5 and 9 | 07 V063 |
PORatt (6) | Porcilis® PRRS | 7 | 07 V063 |
INGatt (6) | Ingelvac® PRRS | 7 | 07 V063 |
Experiment 2 (n) | Â | Â | Â |
CON2 (7) | Mock | 5 and 9 | 08 V194 |
08 V194i (6) | BEI-inactivated 08 V194 | 5 and 9 | 08 V194 |
LVi2 (6) | BEI-inactivated LV | 5 and 9 | 08 V194 |
07 V063i2 (6) | BEI-inactivated 07 V063 | 5 and 9 | 08 V194 |
PORatt2 (6) | Porcilis® PRRS | 7 | 08 V194 |